Trachoma and antibiotic use: the ’A‘ in SAFE

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Review of Anti-Infective Therapy

• Publication date

  2012-01-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1586/eri.11.150PMID 22149616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk Factors for Ocular Infection with Chlamydia trachomatis in Children 6 Months following Mass Treatment in Tanzania

  2011cited by this paper
• Slow resolution of clinically active trachoma following successful mass antibiotic treatments.

  2011cited by this paper
• Antibiotics for trachoma.

  2011cited by this paper
• Adverse events after mass azithromycin treatments for trachoma in Ethiopia.

  2011cited by this paper
• Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania

  2011cited by this paper
• Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites

  2011cited by this paper
• Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma?

  2011cited by this paper
• What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting.

  2011cited by this paper
• Integrated Implementation of Programs Targeting Neglected Tropical Diseases through Preventive Chemotherapy: Proving the Feasibility at National Scale

  2011cited by this paper
• Decreased Susceptibility to Azithromycin and Doxycycline in Clinical Isolates of Chlamydia trachomatis Obtained from Recurrently Infected Female Patients in India

  2010cited by this paper
• Antibiotic Selection Pressure and Macrolide Resistance in Nasopharyngeal Streptococcus pneumoniae: A Cluster-Randomized Clinical Trial

  2010cited by this paper
• Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households

  2010cited by this paper
• Randomized Trial of High Dose Azithromycin Compared to Standard Dosing for Children with Severe Trachoma in Tanzania

  2009cited by this paper
• Estimating Household and Community Transmission of Ocular Chlamydia trachomatis

  2009cited by this paper
• Reduction and Return of Infectious Trachoma in Severely Affected Communities in Ethiopia

  2009cited by this paper
• Mass treatment of trachoma with azithromycin 1.5% eye drops in the Republic of Cameroon: feasibility, tolerance and effectiveness

  2009cited by this paper
• Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma.

  2009cited by this paper
• Trachoma: global magnitude of a preventable cause of blindness

  2008cited by this paper
• Trachoma: A Blinding Scourge from the Bronze Age to the Twenty-first Century

  2008cited by this paper
• Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.

  2008cited by this paper
• Trachoma: A Blinding Scourge from the Bronze Age to the Twenty-first Century

  2008cited by this paper
• Current Concepts Control of Neglected Tropical Diseases

  2007cited by this paper
• Control of neglected tropical diseases.

  2007cited by this paper
• Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.

  2007cited by this paper
• Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.

  2006cited by this paper
• Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study.

  2006cited by this paper
• Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia.

  2006cited by this paper
• Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.

  2005cited by this paper
• Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.

  2005cited by this paper
• Simplification and improvement of height-based azithromycin treatment for paediatric trachoma.

  2005cited by this paper
• Long term outcome of trichiasis surgery in the Gambia

  2005cited by this paper
• Topical ocular antibiotics induce bacterial resistance at extraocular sites

  2005cited by this paper
• Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.

  2005cited by this paper
• Mass treatment with single-dose azithromycin for trachoma.

  2004cited by this paper
• Global data on visual impairment in the year 2002.

  2004cited by this paper
• Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year

  2003cited by this paper
• Azithromycin treatment coverage in Tanzanian children using community volunteers

  2003cited by this paper
• Global burden of trachoma and economics of the disease.

  2003cited by this paper
• Impact of Azithromycin Administration for Trachoma Control on the Carriage of Antibiotic-Resistant Streptococcus pneumoniae

  2003cited by this paper
• Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.

  2002cited by this paper
• Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal.

  2001cited by this paper
• Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana.

  2001cited by this paper
• Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children.

  2001cited by this paper
• The SAFE strategy for trachoma control: Planning a cost-effectiveness analysis of the antibiotic component and beyond

  2001cited by this paper
• Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.

  2000cited by this paper
• Global elimination of trachoma: How frequently should we administer mass chemotherapy?

  1999cited by this paper
• Azithromycin for control of trachoma.

  1999cited by this paper
• Incidence of trichiasis in a cohort of women with and without scarring.

  1999cited by this paper
• Azithromycin in control of trachoma.

  1999cited by this paper
• Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children.

  1999cited by this paper
• The Epidemiology of Eye Disease

  1998cited by this paper
• Chronic progressive conjunctival cicatrisation

  1993cited by this paper
• Latrine ownership as a protective factor in inflammatory trachoma in Egypt.

  1991cited by this paper
• The epidemiology of trachoma in central Tanzania.

  1991cited by this paper
• Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure.

  1989cited by this paper
• Village and household clustering of xerophthalmia and trachoma.

  1988cited by this paper
• A simple system for the assessment of trachoma and its complications.

  1987cited by this paper
• Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

  1987cited by this paper
• Importance of reinfection in the pathogenesis of trachoma.

  1985cited by this paper
• An animal model of trachoma II. The importance of repeated reinfection.

  1982cited by this paper
• Studies in the epidemiology and control of seasonal conjunctivitis and trachoma in southern Morocco.

  1968cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper

• Neglected Tropical Diseases. The Place of Ivermectin in the Elimination Programs

  2021cites this paper
• Bacterial Eye Infections

  2021cites this paper
• Ocular Chlamydia trachomatis infection: elimination with mass drug administration

  2019cites this paper
• Chlamydia trachomatis infection in the Solomon Islands

  2018cites this paper
• CHRONIC TRACHOMA: COMPARISON OF AZITHROMYCIN VERSUS TOPICAL TETRACYCLINE IN RURAL SINDH POPULATION -

  2016cites this paper
• Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands

  2016cites this paper
• Quality Standards and Current Status of Ophthalmic Formulations in Indian Pharmacopoeia and National Formulary of India

  2014cites this paper
• Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.

  2014cites this paper
• The Limits of Medical Interventions for the Elimination of Preventable Blindness

  2014cites this paper
• Enhancing community knowledge and health behaviors to eliminate blinding trachoma in Mali using radio messaging as a strategy.

  2013cites this paper
• Trachoma: an update on prevention, diagnosis, and treatment

  2012cites this paper